The methods and compositions diagnosing lung cancer, determining prognosis, and improving patient survival based on the levels or gene status of certain microRNAs (miRNA), are provided. The compositions comprise a reagent for reducing miRNA level, and a use method used for facilitating survival of a patient is also provided.